Innoue et al. reported that the expression of VEGF in biopsy specimens was correlated with the prognosis of patients with advanced bladder cancer undergoing neoadjuvant chemotherapy and cystectomy [79]. The gene discussed is VEGFA; the disease is urinary bladder cancer.